MiRus's $1.5B: A Medtech Megaround in an AI-Dominated Market
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
2026 venture capital activity reflects a market balancing AI infrastructure bets, selective growth equity, and renewed interest in capital-efficient startups. Our coverage tracks the rounds, fund launches, and strategic shifts that matter for founders and investors.
Read the latest 2026 VC news and funding roundups below.
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
benefitbay raised $18M led by Ten Coves Capital to scale broker-first ICHRA administration — payments, carriers, and payroll integrations in focus.
San Jose-based Hark raised $700M+ Series A at $6B post-money for personalized intelligence — a reminder that frontier AI capital has no ceiling.
Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.
Primer raised $100M Series C from Sofina and Peak XV to scale AI-native payments — US ARR doubling YoY as autonomous finance ops go mainstream.
National Bank of Canada led Sardine's $25M Series C extension after live deployment — total funding hits $170M as agentic fraud AI scales.